The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...

Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...

Intensive BP lowering after successful endovascular thrombectomy for acute anterior circulation ischemic stroke did not improve 90-day functional outcomes vs. standard BP control, a speaker ...

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...

PUNE: The number of suspected Guillain-Barre Syndrome (GBS) deaths in Maharashtra's Pune district has risen to six after a 63-year-old man died, a health official has said. The man was admitted to a ...

A 63-year-old resident of Vadarvasti in Karve Nagar, Pune, succumbed to complications arising from Guillain-Barré Syndrome ...

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world's first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system-the ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.